CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer.
Ang JE, Olmos D, de Bono JS.
Br J Cancer. 2009 Mar 10;100(5):671-5. Epub 2009 Feb 17.
PMID: 19223900
doi:10.1038/sj.bjc.6604904